The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78 (Q57279306)
Jump to navigation
Jump to search
scientific article published on 24 November 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78 |
scientific article published on 24 November 2010 |
Statements
The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78 (English)
Patricia Pérez-Galán
Mónica López-Guerra
Laia Rosich
Ifigènia Saborit-Villarroya
Emmanuel Normant
24 November 2010